321 related articles for article (PubMed ID: 34980259)
1. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K).
Beretta S; Gritti L; Ponzoni L; Scalmani P; Mantegazza M; Sala M; Verpelli C; Sala C
Mol Autism; 2022 Jan; 13(1):1. PubMed ID: 34980259
[TBL] [Abstract][Full Text] [Related]
2. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
Niibori Y; Lee SJ; Minassian BA; Hampson DR
Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
[TBL] [Abstract][Full Text] [Related]
3. Adolescent behavioral abnormalities in a Scn1a
Bahceci D; Anderson LL; Occelli Hanbury Brown CV; Zhou C; Arnold JC
Epilepsy Behav; 2020 Feb; 103(Pt A):106842. PubMed ID: 31870807
[TBL] [Abstract][Full Text] [Related]
4. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
[TBL] [Abstract][Full Text] [Related]
5. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
Miller AR; Hawkins NA; McCollom CE; Kearney JA
Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice.
Yamagata T; Raveau M; Kobayashi K; Miyamoto H; Tatsukawa T; Ogiwara I; Itohara S; Hensch TK; Yamakawa K
Neurobiol Dis; 2020 Jul; 141():104954. PubMed ID: 32445790
[TBL] [Abstract][Full Text] [Related]
7. Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model.
Miljanovic N; Hauck SM; van Dijk RM; Di Liberto V; Rezaei A; Potschka H
Neurobiol Dis; 2021 Sep; 157():105423. PubMed ID: 34144125
[TBL] [Abstract][Full Text] [Related]
8. Cell-Selective Adeno-Associated Virus-Mediated
Tanenhaus A; Stowe T; Young A; McLaughlin J; Aeran R; Lin IW; Li J; Hosur R; Chen M; Leedy J; Chou T; Pillay S; Vila MC; Kearney JA; Moorhead M; Belle A; Tagliatela S
Hum Gene Ther; 2022 Jun; 33(11-12):579-597. PubMed ID: 35435735
[TBL] [Abstract][Full Text] [Related]
9. Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome.
Valassina N; Brusco S; Salamone A; Serra L; Luoni M; Giannelli S; Bido S; Massimino L; Ungaro F; Mazzara PG; D'Adamo P; Lignani G; Broccoli V; Colasante G
Nat Commun; 2022 Jan; 13(1):161. PubMed ID: 35013317
[TBL] [Abstract][Full Text] [Related]
10. Dravet Syndrome: A Developmental and Epileptic Encephalopathy.
Lopez-Santiago L; Isom LL
Epilepsy Curr; 2019 Jan; 19(1):51-53. PubMed ID: 30838929
[TBL] [Abstract][Full Text] [Related]
11. Life-span characterization of epilepsy and comorbidities in Dravet syndrome mice carrying a targeted deletion of exon 1 of the Scn1a gene.
Gerbatin RR; Augusto J; Boutouil H; Reschke CR; Henshall DC
Exp Neurol; 2022 Aug; 354():114090. PubMed ID: 35487274
[TBL] [Abstract][Full Text] [Related]
12. dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.
Colasante G; Lignani G; Brusco S; Di Berardino C; Carpenter J; Giannelli S; Valassina N; Bido S; Ricci R; Castoldi V; Marenna S; Church T; Massimino L; Morabito G; Benfenati F; Schorge S; Leocani L; Kullmann DM; Broccoli V
Mol Ther; 2020 Jan; 28(1):235-253. PubMed ID: 31607539
[TBL] [Abstract][Full Text] [Related]
13. Convulsive seizures and some behavioral comorbidities are uncoupled in the Scn1a
Fadila S; Quinn S; Turchetti Maia A; Yakubovich D; Ovadia M; Anderson KL; Giladi M; Rubinstein M
Epilepsia; 2020 Oct; 61(10):2289-2300. PubMed ID: 32865826
[TBL] [Abstract][Full Text] [Related]
14. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
15. Synaptic Integration in CA1 Pyramidal Neurons Is Intact despite Deficits in GABAergic Transmission in the
Chancey JH; Howard MA
eNeuro; 2022; 9(3):. PubMed ID: 35523580
[TBL] [Abstract][Full Text] [Related]
16. Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.
Ricobaraza A; Bunuales M; Gonzalez-Aparicio M; Fadila S; Rubinstein M; Vides-Urrestarazu I; Banderas J; Sola-Sevilla N; Sanchez-Carpintero R; Lanciego JL; Roda E; Honrubia A; Arnaiz P; Hernandez-Alcoceba R
J Mol Med (Berl); 2023 Dec; 101(12):1587-1601. PubMed ID: 37819378
[TBL] [Abstract][Full Text] [Related]
17. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice.
Hawkins NA; Jurado M; Thaxton TT; Duarte SE; Barse L; Tatsukawa T; Yamakawa K; Nishi T; Kondo S; Miyamoto M; Abrahams BS; During MJ; Kearney JA
Epilepsia; 2021 Nov; 62(11):2845-2857. PubMed ID: 34510432
[TBL] [Abstract][Full Text] [Related]
18. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
[TBL] [Abstract][Full Text] [Related]
19. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies.
Mei D; Cetica V; Marini C; Guerrini R
Epilepsia; 2019 Dec; 60 Suppl 3():S2-S7. PubMed ID: 31904125
[TBL] [Abstract][Full Text] [Related]
20. Genetic therapeutic advancements for Dravet Syndrome.
Chilcott E; Díaz JA; Bertram C; Berti M; Karda R
Epilepsy Behav; 2022 Jul; 132():108741. PubMed ID: 35653814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
